Persistent Cervical Cancer

DrugDrug NameDrug Description
DB00112BevacizumabA monoclonal anti-vascular endothelial growth factor antibody used in combination with antineoplastic agents for the treatment of many types of cancer.
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DrugDrug NamePhaseStatusCount
DB00112Bevacizumab2Recruiting1
DB08875Cabozantinib2Terminated1
DB14776Camrelizumab2Recruiting1
DB00958Carboplatin2Recruiting1
DB00515Cisplatin2Recruiting1
DB01229Paclitaxel2Recruiting1
DB09037Pembrolizumab2Terminated1
DB14765Rivoceranib2Recruiting1